Kazia therapeutics appoints karen krumeich as chief financial officer

Sydney, dec. 13, 2021 /prnewswire/ -- kazia therapeutics limited (nasdaq: kzia; asx: kza), an oncology-focused drug development company, is pleased to announce the appointment of karen krumeich as chief financial officer. in this role, ms krumeich will focus on building and maintaining relationships with us investors, on preparing the company for future expansion, and on raising the profile of kazia in global markets.
KZIA Ratings Summary
KZIA Quant Ranking